2-21044060-G-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000384.3(APOB):​c.-115C>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0127 in 425,854 control chromosomes in the GnomAD database, including 62 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.018 ( 35 hom., cov: 32)
Exomes 𝑓: 0.0099 ( 27 hom. )

Consequence

APOB
NM_000384.3 5_prime_UTR

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 1.49
Variant links:
Genes affected
APOB (HGNC:603): (apolipoprotein B) This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins (LDL), and is the ligand for the LDL receptor. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. [provided by RefSeq, Dec 2019]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 2-21044060-G-C is Benign according to our data. Variant chr2-21044060-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 265871.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=1, Benign=1}.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0177 (2699/152250) while in subpopulation AFR AF = 0.0364 (1512/41578). AF 95% confidence interval is 0.0348. There are 35 homozygotes in GnomAd4. There are 1223 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 35 SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
APOBNM_000384.3 linkc.-115C>G 5_prime_UTR_variant Exon 1 of 29 ENST00000233242.5 NP_000375.3 P04114Q7Z7Q0Q59HB3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
APOBENST00000233242.5 linkc.-115C>G 5_prime_UTR_variant Exon 1 of 29 1 NM_000384.3 ENSP00000233242.1 P04114

Frequencies

GnomAD3 genomes
AF:
0.0177
AC:
2699
AN:
152134
Hom.:
34
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0365
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0141
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.0103
Gnomad FIN
AF:
0.00274
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0125
Gnomad OTH
AF:
0.0167
GnomAD4 exome
AF:
0.00988
AC:
2703
AN:
273604
Hom.:
27
Cov.:
5
AF XY:
0.00932
AC XY:
1290
AN XY:
138474
show subpopulations
Gnomad4 AFR exome
AF:
0.0392
AC:
241
AN:
6154
Gnomad4 AMR exome
AF:
0.00646
AC:
35
AN:
5420
Gnomad4 ASJ exome
AF:
0.000444
AC:
3
AN:
6758
Gnomad4 EAS exome
AF:
0.000232
AC:
4
AN:
17264
Gnomad4 SAS exome
AF:
0.00911
AC:
35
AN:
3840
Gnomad4 FIN exome
AF:
0.00465
AC:
87
AN:
18726
Gnomad4 NFE exome
AF:
0.0105
AC:
2096
AN:
199642
Gnomad4 Remaining exome
AF:
0.0129
AC:
190
AN:
14704
Heterozygous variant carriers
0
133
267
400
534
667
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0177
AC:
2699
AN:
152250
Hom.:
35
Cov.:
32
AF XY:
0.0164
AC XY:
1223
AN XY:
74452
show subpopulations
Gnomad4 AFR
AF:
0.0364
AC:
0.0363654
AN:
0.0363654
Gnomad4 AMR
AF:
0.0141
AC:
0.0141195
AN:
0.0141195
Gnomad4 ASJ
AF:
0.00
AC:
0
AN:
0
Gnomad4 EAS
AF:
0.000387
AC:
0.000386847
AN:
0.000386847
Gnomad4 SAS
AF:
0.0106
AC:
0.0105634
AN:
0.0105634
Gnomad4 FIN
AF:
0.00274
AC:
0.00273585
AN:
0.00273585
Gnomad4 NFE
AF:
0.0125
AC:
0.0125471
AN:
0.0125471
Gnomad4 OTH
AF:
0.0165
AC:
0.0165406
AN:
0.0165406
Heterozygous variant carriers
0
148
296
443
591
739
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00586
Hom.:
3
Bravo
AF:
0.0194
Asia WGS
AF:
0.00722
AC:
25
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Hypercholesterolemia, familial, 1 Uncertain:1
Mar 01, 2016
Cardiovascular Research Group, Instituto Nacional de Saude Doutor Ricardo Jorge
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

Hypercholesterolemia, autosomal dominant, type B Benign:1
Apr 24, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Familial hypercholesterolemia Benign:1
Aug 03, 2023
GENinCode PLC
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
7.4
DANN
Benign
0.71
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1800480; hg19: chr2-21266932; API